INViCARE
PrivateLast Round
Grant
Apr 5, 2018
Total Funding Raised
$5,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
INViCARE operates in Healthcare & Life Sciences and is based in Montreal. Its latest recorded funding round was a Grant round in April 2018.
INViCARE is a biotechnology company that develops nanocrystalline biomaterials designed to prevent and treat dental implant infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
INViCARE Comparables
Compare INViCARE with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Regedent AG | 83% | |
| RLS Global AB | 79% | |
| Prudentix Ltd. | 78% |
For institutional investors. Book with your work email.
INViCARE Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 5, 2018 | ||||
| Grant | Jun 8, 2017 |
For institutional investors. Book with your work email.
INViCARE Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mitacs | Grant |
| Centech | Accelerator |
| McGill Dobson Centre for Entrepreneurship | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 79% MoM, from 258 to 461.
- Jun 8, 2017
$5K grant received from Mitacs
For institutional investors. Book with your work email.
INViCARE Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about INViCARE's valuation, stock price, and market status.
Is INViCARE a public or private company?
INViCARE is a private company.
What is the current stock price of INViCARE?
INViCARE is a private company, so its shares have no public market price. Caplight tracks INViCARE's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is INViCARE worth (valuation)?
Valuation information for INViCARE is not publicly available.
Can I buy INViCARE stock?
INViCARE shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was INViCARE's last funding round?
INViCARE's most recent funding round was Grant on April 5, 2018.
Who are the main investors in INViCARE?
Key investors in INViCARE include Mitacs, Centech, McGill Dobson Centre for Entrepreneurship.
Will INViCARE IPO soon?
No public IPO plans have been announced for INViCARE.
How can I track INViCARE secondary market activity?
Caplight tracks bids, offers, and trades in INViCARE's shares on secondary markets.